It appears to be very useful for identifying patients with low risks of retaining video capsules: those whom the capsule passes completely through within the first 30 hours after ingestion are likely to have low risk for video capsule retention 60, 61.
Parece ser muy útil para identificar pacientes de bajo riesgo para retención de la cápsula, y para quienes la retención de la cápsula video ocurrirá raramente 60, 61.